Trial Profile
Ofatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic Transplantation(CLL-X4 Trial)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Ofatumumab (Primary) ; Dexamethasone
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 16 Sep 2016 Status changed from recruiting to completed.
- 20 Mar 2013 New source identified and integrated: European Clinical Trials Database record.
- 19 Mar 2013 New trial record